Kira M. Schwartz
Secretario Corporativo en VITAE PHARMACEUTICALS INC .
Perfil
Kira M.
Schwartz is a professional with a career history that includes current and former positions, as well as education.
Currently, Ms. Schwartz works as a Secretary at Vitae Pharmaceuticals LLC.
Previously, Ms. Schwartz worked as a Secretary at Allergan GI Corp.
and Tobira Therapeutics, Inc. Additionally, Ms. Schwartz worked as a General Counsel at Prevail Therapeutics, Inc. Ms. Schwartz received an undergraduate degree from Tufts University and a graduate degree from Yale Law School.
Cargos activos de Kira M. Schwartz
Empresas | Cargo | Inicio |
---|---|---|
VITAE PHARMACEUTICALS INC | Secretario Corporativo | 25/10/2016 |
Antiguos cargos conocidos de Kira M. Schwartz.
Empresas | Cargo | Fin |
---|---|---|
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Secretario Corporativo | - |
TOBIRA THERAPEUTICS INC | Secretario Corporativo | - |
PREVAIL THERAPEUTICS INC. | Consejero General | - |
Formación de Kira M. Schwartz.
Yale Law School | Graduate Degree |
Tufts University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Prevail Therapeutics, Inc.
Prevail Therapeutics, Inc. BiotechnologyHealth Technology Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY. | Health Technology |
Vitae Pharmaceuticals LLC
Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Health Technology |
Tobira Therapeutics, Inc.
Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on September 11, 2006 and is headquartered in Madison, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Kira M. Schwartz